[LIPO] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[LIPO] Lipella Pharmaceuticals Inc.
Announcement Date
31-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 49.09%
YoY- 5.71%
Quarter Report
LIPO's Result
LIPO's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 104,051 106,676 118 151 0 0 33 21297.35%
PBT -1,324 -1,539 -1,068 -364 -714 -782 -738 47.59%
Tax 33,124 36,477 -11,213 -1 -1 -1 -0 -
NP -1,324 -1,539 10,145 -363 -713 -781 -738 47.59%
Tax Rate - - - - - - - -
Total Cost 105,375 108,215 -10,027 514 713 781 771 2545.39%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin -1.27 -1.44 8,594.11 -240.25 0.00 0.00 -2,225.17 -99.30%
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -0.23 -0.27 1.77 -0.06 -0.12 -0.14 -0.13 46.23%
EPS Diluted -0.23 -0.27 1.77 -0.06 -0.12 -0.14 -0.13 46.23%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.